256 related articles for article (PubMed ID: 18566174)
1. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.
Kantarci K; Knopman DS; Dickson DW; Parisi JE; Whitwell JL; Weigand SD; Josephs KA; Boeve BF; Petersen RC; Jack CR
Radiology; 2008 Jul; 248(1):210-20. PubMed ID: 18566174
[TBL] [Abstract][Full Text] [Related]
2. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
[TBL] [Abstract][Full Text] [Related]
4. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.
Jack CR; Dickson DW; Parisi JE; Xu YC; Cha RH; O'Brien PC; Edland SD; Smith GE; Boeve BF; Tangalos EG; Kokmen E; Petersen RC
Neurology; 2002 Mar; 58(5):750-7. PubMed ID: 11889239
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
6. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage.
Vemuri P; Whitwell JL; Kantarci K; Josephs KA; Parisi JE; Shiung MS; Knopman DS; Boeve BF; Petersen RC; Dickson DW; Jack CR
Neuroimage; 2008 Aug; 42(2):559-67. PubMed ID: 18572417
[TBL] [Abstract][Full Text] [Related]
7. 1H MR spectroscopy in common dementias.
Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
[TBL] [Abstract][Full Text] [Related]
8. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
[TBL] [Abstract][Full Text] [Related]
9. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.
Catani M; Cherubini A; Howard R; Tarducci R; Pelliccioli GP; Piccirilli M; Gobbi G; Senin U; Mecocci P
Neuroreport; 2001 Aug; 12(11):2315-7. PubMed ID: 11496102
[TBL] [Abstract][Full Text] [Related]
10. Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Shonk TK; Moats RA; Gifford P; Michaelis T; Mandigo JC; Izumi J; Ross BD
Radiology; 1995 Apr; 195(1):65-72. PubMed ID: 7892497
[TBL] [Abstract][Full Text] [Related]
11. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
[TBL] [Abstract][Full Text] [Related]
12. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease.
Chantal S; Labelle M; Bouchard RW; Braun CM; Boulanger Y
Arch Neurol; 2002 Jun; 59(6):955-62. PubMed ID: 12056931
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
Beach TG; Monsell SE; Phillips LE; Kukull W
J Neuropathol Exp Neurol; 2012 Apr; 71(4):266-73. PubMed ID: 22437338
[TBL] [Abstract][Full Text] [Related]
14. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
15. Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.
Bartha R; Megyesi JF; Watling CJ
AJNR Am J Neuroradiol; 2008 Mar; 29(3):464-70. PubMed ID: 18238848
[TBL] [Abstract][Full Text] [Related]
16. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
[TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
Ernst T; Chang L; Melchor R; Mehringer CM
Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice.
Forster D; Davies K; Williams S
Magn Reson Med; 2013 Apr; 69(4):944-55. PubMed ID: 22760762
[TBL] [Abstract][Full Text] [Related]
19. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
[TBL] [Abstract][Full Text] [Related]
20. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
Antuono PG; Jones JL; Wang Y; Li SJ
Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
